New Regulatory Regime for 8 Medical Devices under D&C Act

The Ministry had earlier notified the following medical items to be regulated under the Drugs and Cosmetics Act which was to come into effect from 1st April, 2021

279
Doctor Hospital
Picture: Pixabay

Adopting a proactive and sensitive approach to address the needs of the Indian Industry, the Union Ministry of Health & Family Welfare has taken a significant decision for ensuring continued access of eight regulated medical devices today.

The Ministry had earlier notified the following medical devices to be regulated under the Drugs and Cosmetics Act which was to come into effect from 1st April, 2021 (as per S.O. 775(E) dated 08th February, 2019 under Medical Devices Rules 2017):

Bp Apparatus, Medical Devices
Picture: Pixabay

To read or download above said S.O. 775(E) dated 08th February, 2019 under Medical Devices Rules 2017, click here


  1. All Implantable Medical Devices;
  2. CT scan equipment;
  3. MRI equipment;
  4. Defibrillators;
  5. PET Equipment;
  6. Dialysis Machine;
  7. X-Ray Machine; and
  8. Bone marrow cell separator.

Accordingly, as per the said order the importers/manufacturers are required to take import/manufacturing licence from Central Licencing Authority or State Licencing Authority, as the case may be, for import/manufacture of above devices, w.e.f. 1st April, 2021.


Also read:

For more details on licensing process of Medical devices, click here

For notifications of Medical Devices, click here


Transition time of 6 months allowed for ensuring supply chain continuity and access while implementing their regulatory order under Medical Devices Rules (2017)

Order in this regard has been issued by Drugs Controller General (India) on 18th April 2021 through CDSCO website.

DCGI CDSCO

To read or download DCGI Order dated 18-04-2021, click here


In order to ensure  supply chain continuity and access to these Medical Devices, while implementing  smooth transition into the new regulatory regime, Union Ministry of Health and Family Welfare hasnow decided that in case an existing importer/manufacturer who is already importing /manufacturing any of these devices, has submitted application to Central Licencing Authority or State Licencing Authority, as the case may be, for grant of import /manufacturing licence in respect of the said device(s) under the provisions of MDR, 2017, the said application shall be deemed valid and the importer/manufacturer can continue to import /manufacture the said device(s) up to 6 months from issue of this order or till the time, the Central Licencing Authority or State Licencing Authority, as the case may be, takes a decision on the said application, whichever is earlier.


Also read:

Latest Circulars, Notices & Guidelines: CDSCO, DCGI

New price of Remdesivir injection, prices reduced by 7 companies: NPPA

Retail and Wholesale Pharmacies rises in Odisha

Health Parliament urges PM to declare National Health Emergency in the…

NPPA directs reduction in Remdesivir price

Police arrest 4 for selling fake Remdesivir injections


Enter your email address:

Delivered by FeedBurner

Latest updates

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Subscribe here for daily updates
Loading